Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 2
2012 1
2014 1
2015 1
2018 1
2019 2
2020 7
2021 7
2022 9
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac sarcoidosis: diagnosis and management.
Markatis E, Afthinos A, Antonakis E, Papanikolaou IC. Markatis E, et al. Among authors: papanikolaou ic. Rev Cardiovasc Med. 2020 Sep 30;21(3):321-338. doi: 10.31083/j.rcm.2020.03.102. Rev Cardiovasc Med. 2020. PMID: 33070538 Free article. Review.
Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial.
Giamarellos-Bourboulis EJ, Siampanos A, Bolanou A, Doulou S, Kakavoulis N, Tsiakos K, Katopodis S, Schinas G, Skorda L, Alexiou Z, Armenis K, Katsaounou P, Chrysos G, Masgala A, Poulakou G, Antonakos N, Safarika A, Kyprianou M, Dakou K, Gerakari S, Papanikolaou IC, Milionis H, Marangos M, Dalekos GN, Tzavara V, Akinosoglou K, Hatziaggelaki E, Sympardi S, Kontopoulou T, Mouktaroudi M, Papadopoulos A, Niederman MS. Giamarellos-Bourboulis EJ, et al. Among authors: papanikolaou ic. Lancet Respir Med. 2024 Apr;12(4):294-304. doi: 10.1016/S2213-2600(23)00412-5. Epub 2024 Jan 3. Lancet Respir Med. 2024. PMID: 38184008 Clinical Trial.
Vaccination in the Era of Immunosuppression.
Alnaimat F, Sweis JJG, Jansz J, Modi Z, Prasad S, AbuHelal A, Vagts C, Hanson HA, Ascoli C, Novak RM, Papanikolaou IC, Rubinstein I, Sweiss N. Alnaimat F, et al. Among authors: papanikolaou ic. Vaccines (Basel). 2023 Sep 1;11(9):1446. doi: 10.3390/vaccines11091446. Vaccines (Basel). 2023. PMID: 37766123 Free PMC article. Review.
State-of-the-Art Treatments for Sarcoidosis.
Papanikolaou IC, Antonakis E, Pandi A. Papanikolaou IC, et al. Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):94-105. doi: 10.14797/mdcvj.1068. eCollection 2022. Methodist Debakey Cardiovasc J. 2022. PMID: 35772032 Free PMC article. Review.
Acute exacerbations of interstitial lung diseases.
Papanikolaou IC, Drakopanagiotakis F, Polychronopoulos VS. Papanikolaou IC, et al. Curr Opin Pulm Med. 2010 Sep;16(5):480-6. doi: 10.1097/MCP.0b013e32833ae49d. Curr Opin Pulm Med. 2010. PMID: 20473169 Review.
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe.
Karampitsakos T, Spagnolo P, Mogulkoc N, Wuyts WA, Tomassetti S, Bendstrup E, Molina-Molina M, Manali ED, Unat ÖS, Bonella F, Kahn N, Kolilekas L, Rosi E, Gori L, Ravaglia C, Poletti V, Daniil Z, Prior TS, Papanikolaou IC, Aso S, Tryfon S, Papakosta D, Tzilas V, Balestro E, Papiris S, Antoniou K, Bouros D, Wells A, Kreuter M, Tzouvelekis A. Karampitsakos T, et al. Among authors: papanikolaou ic. Respirology. 2023 Jan;28(1):56-65. doi: 10.1111/resp.14363. Epub 2022 Sep 18. Respirology. 2023. PMID: 36117239
An unusual disease with an interesting sign.
Afthinos A, Antonakis E, Horti M, Markatis E, Pagratis K, Papanikolaou IC. Afthinos A, et al. Among authors: papanikolaou ic. Breathe (Sheff). 2020 Mar;16(1):190302. doi: 10.1183/20734735.0302-2019. Breathe (Sheff). 2020. PMID: 32194763 Free PMC article.
Amiodarone and diffuse alveolar hemorrhage.
Papanikolaou IC, Makou I, Markatis E. Papanikolaou IC, et al. Adv Respir Med. 2020;88(2):169-171. doi: 10.5603/ARM.2020.0095. Adv Respir Med. 2020. PMID: 32383473 Free article. No abstract available.
Predictors of Mortality in Tocilizumab-Treated Severe COVID-19.
Pagkratis K, Chrysikos S, Antonakis E, Pandi A, Kosti CN, Markatis E, Hillas G, Digalaki A, Koukidou S, Chaini E, Afthinos A, Dimakou K, Papanikolaou IC. Pagkratis K, et al. Among authors: papanikolaou ic. Vaccines (Basel). 2022 Jun 20;10(6):978. doi: 10.3390/vaccines10060978. Vaccines (Basel). 2022. PMID: 35746585 Free PMC article.
36 results